Bulletin
Investor Alert

Sotera Health Co.

NAS: SHC

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Sotera Health Co.

After Hours

 --Quotes are delayed by 20 min

Jan 14, 2022, 4:01 p.m.

SHC
/zigman2/quotes/222596028/composite

$

21.76

Change

0.00 0.00%

Volume

Volume 7,111

Quotes are delayed by 20 min

/zigman2/quotes/222596028/composite

Previous close

$ 21.29

$ 21.76

Change

+0.47 +2.21%

Day low

Day high

$21.10

$21.78

Open

52 week low

52 week high

$20.48

$30.38

Open

Company Description

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmac...

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The company operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.

Valuation

P/E Ratio (with extraordinary items)

159.70

Price to Sales Ratio

9.50

Price to Book Ratio

17.18

Price to Cash Flow Ratio

64.46

Enterprise Value to EBITDA

19.03

Enterprise Value to Sales

8.46

Total Debt to Enterprise Value

0.20

Efficiency

Revenue/Employee

272,719.00

Income Per Employee

-12,872.00

Receivables Turnover

6.74

Total Asset Turnover

0.31

Liquidity

Current Ratio

2.24

Quick Ratio

1.98

Cash Ratio

0.73

Profitability

Gross Margin

47.00

Operating Margin

31.48

Pretax Margin

-4.75

Net Margin

-4.72

Return on Assets

-1.45

Return on Total Capital

11.20

Return on Invested Capital

-1.70

Capital Structure

Total Debt to Total Equity

422.11

Total Debt to Total Capital

80.85

Total Debt to Total Assets

69.14

Long-Term Debt to Equity

419.78

Long-Term Debt to Total Capital

80.40

Officers and Executives

Name Age Officer Since Title
Mr. Michael B. Petras 52 2016 Chairman & Chief Executive Officer
Mr. Scott J. Leffler 44 2017 Chief Financial Officer & Treasurer
Mr. Robert G. Hauzie - 2019 Chief Information Officer
Mr. Michael P. Rutz 48 2020 President-Sterigenics
Mr. Kurt M. Roth - 2015 Senior VP-Corporate Development & Strategy

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/20/2021 Michael B. Petras
Chairman & CEO; Director 		27,517   Derivative/Non-derivative trans. at $22.54 per share. 620,233
11/20/2021 Scott J. Leffler
CFO and Treasurer 		3,894   Derivative/Non-derivative trans. at $22.54 per share. 87,770
11/20/2021 Michael P. Rutz
President of Sterigenics 		1,911   Derivative/Non-derivative trans. at $22.54 per share. 43,073
11/11/2021 Terrence G. Hammons
SVP, GC and Secretary 		8,791   Award at $0 per share. 0
08/25/2021 Michael P. Rutz
President of Sterigenics 		67,000   Disposition at $25.03 per share. 1,677,010
05/28/2021 Ann R. Klee
Director 		9,336   Award at $0 per share. 0
05/28/2021 Vincent Kevin Petrella
Director 		9,336   Award at $0 per share. 0
05/28/2021 Dave Anthony Donnini
Director 		9,336   Award at $0 per share. 0
05/28/2021 Dean Spyro Mihas
Director 		9,336   Award at $0 per share. 0
05/28/2021 Sean Laurence Cunningham
Director 		9,336   Award at $0 per share. 0
05/28/2021 James C. Neary
Director 		9,336   Award at $0 per share. 0
05/28/2021 Ruoxi Chen
Director 		9,336   Award at $0 per share. 0
05/28/2021 Stephanie Geveda
Director 		9,336   Award at $0 per share. 0
05/28/2021 David E. Wheadon
Director 		9,336   Award at $0 per share. 0
03/22/2021 Warburg Pincus LLC
Director 		13,512,582   Disposition at $26.12 per share. 352,948,641
03/22/2021 Warburg Pincus LLC
Director 		13,512,582   Disposition at $26.12 per share. 352,948,641
03/22/2021 GTCR LLC
Director 		9,008,388   Disposition at $26.12 per share. 235,299,094
03/22/2021 Michael B. Petras
Chairman & CEO; Director 		817,439   Disposition at $26.12 per share. 21,351,506
03/22/2021 Matthew J. Klaben
SVP, GC and Secretary 		41,952   Disposition at $26.12 per share. 1,095,786
11/24/2020 Michael B. Petras
Chairman & CEO; Director 		946,102   20,511,491
11/24/2020 Michael B. Petras
Chairman & CEO; Director 		437,821   9,491,959
11/24/2020 Scott J. Leffler
CFO and Treasurer 		115,326   2,500,267
11/24/2020 Matthew J. Klaben
SVP, GC and Secretary 		69,196   1,500,169
11/20/2020 GTCR LLC
Director 		5,869   Award at $0 per share. 0
11/20/2020 Michael B. Petras
Chairman & CEO; Director 		260,869   Award at $0 per share. 0
11/20/2020 Scott J. Leffler
CFO and Treasurer 		52,173   Award at $0 per share. 0
11/20/2020 Michael P. Rutz
President of Sterigenics 		26,086   Award at $0 per share. 0
11/20/2020 Matthew J. Klaben
SVP, GC and Secretary 		31,304   Award at $0 per share. 0
11/20/2020 Ann R. Klee
Director 		5,869   Award at $0 per share. 0
11/20/2020 Vincent Kevin Petrella
Director 		5,869   Award at $0 per share. 0
11/20/2020 Dean Spyro Mihas
Director 		5,869   Award at $0 per share. 0
11/20/2020 Sean Laurence Cunningham
Director 		5,869   Award at $0 per share. 0
11/20/2020 James C. Neary
Director 		5,869   Award at $0 per share. 0
11/20/2020 Ruoxi Chen
Director 		5,869   Award at $0 per share. 0
11/20/2020 Stephanie Geveda
Director 		5,869   Award at $0 per share. 0
/news/latest/company/us/shc

MarketWatch News on SHC

  1. Inflation Ran Hot in December. 15 Stocks to Help Tame It.

    8:56 a.m. Jan. 12, 2022

    - Barron's Online

  2. Sotera Health started at overweight with $35 stock price target at J.P. Morgan

    8:24 a.m. Dec. 15, 2020

    - Tomi Kilgore

  3. Stocks end the week on a downbeat as rising COVID cases weigh

    4:27 p.m. Nov. 20, 2020

    - Mark DeCambre

  4. Maravai LifeSciences Jumps Nearly 19% in IPO. Sotera Pops 17%.

    1:33 p.m. Nov. 20, 2020

    - Barron's Online

  6. Sotera Health's stock opens at $27.00, or 17% above IPO price

    12:04 p.m. Nov. 20, 2020

    - Tomi Kilgore

  7. Sotera Health's stock now indicated to open around $26.15, or 13.7% above the IPO price

    11:10 a.m. Nov. 20, 2020

    - Tomi Kilgore

  8. Sotera Health's stock indicated to open around $25.20, or 9.6% above the $23 IPO price

    10:42 a.m. Nov. 20, 2020

    - Tomi Kilgore

  11. Sotera Health sets IPO terms, to offer 46.6 mln shares priced at $20 to $23 each

    6:52 a.m. Nov. 12, 2020

    - Ciara Linnane

/news/nonmarketwatch/company/us/shc

Other News on SHC

  2. Sotera Health provides FY21 revenue guidance

    7:11 a.m. Jan. 11, 2022

    - Seeking Alpha

  6. Sotera Health Company (SHC) Q3 2021 Earnings Call Transcript

    3:31 a.m. Nov. 11, 2021

    - Motley Fool

  7. 10-Q: SOTERA HEALTH CO

    4:21 p.m. Nov. 10, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  8. Why Sotera Health Stock Is Falling Today

    1:36 p.m. Nov. 10, 2021

    - Motley Fool

  10. Two Creeks Capital Management, LP Buys Amazon. ...

    1:38 p.m. Oct. 26, 2021

    - GuruFocus.com

  14. Sotera Health Company (SHC) Q2 2021 Earnings Call Transcript

    7:00 p.m. Aug. 12, 2021

    - Motley Fool

  15. 10-Q: SOTERA HEALTH CO

    3:18 p.m. Aug. 12, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  21. Loading more headlines...

At a Glance

Sotera Health Co.

9100 South Hills Boulevard

Suite 300

Broadview Heights, Ohio 44147

Phone

1 4402621410

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

View SEC Filings

Revenue

$818.16M

Net Income

$-38.62M

2020 Sales Growth

5.1%

Employees

3,000

Annual Report for SHC

/news/pressrelease/company/us/shc

Press Releases on SHC

  5. Sotera Health Announces Q3 2021 Earnings Release Date

    7:36 a.m. Oct. 15, 2021

    - GlobeNewswire

  9. Sotera Health Announces Q2 2021 Earnings Release Date

    7:00 a.m. July 12, 2021

    - GlobeNewswire

  10. Sotera Health Co to Host Earnings Call

    6:15 a.m. May 13, 2021

    - ACCESSWIRE

  11. Sotera Health Reports First-Quarter 2021 Results

    6:00 a.m. May 13, 2021

    - GlobeNewswire

  12. Organogenesis Appoints Jon Giacomin to Board of Directors

    6:30 a.m. May 10, 2021

    - GlobeNewswire

  14. Sotera Health Announces Pricing of Secondary Offering

    5:50 p.m. March 17, 2021

    - GlobeNewswire

  15. Sotera Health Announces Secondary Offering of Common Stock

    3:33 p.m. March 15, 2021

    - GlobeNewswire

  18. Sotera Health to Present at Upcoming Healthcare Conferences

    8:01 a.m. Feb. 16, 2021

    - GlobeNewswire

Trending Tickers
  • /zigman2/quotes/208747069/composite GEVO+7.77%
  • /zigman2/quotes/228313454/composite CNTX+0.36%
  • /zigman2/quotes/214140886/composite CHPT+5.01%
  • /zigman2/quotes/208173073/composite SFIX+4.61%
  • /zigman2/quotes/222642382/composite OLMA+5.43%
X
Powered by StockTwits
Link to MarketWatch's Slice.